Effect of Thyroid Disorders in Liver Diseases

Status Not yet recruiting

Clinical Trial Summary

Aims of the Research 1. To detect correlation between hyperthyroidism and non alcoholic fatty liver disease (NAFLD). 2. To detect hepatic risk in subclinical and clinical hypothyroidism . 3. To detect early liver disorders in thyroid disorders using fibroscan .

Clinical Trial Description

Non alcoholic fatty liver disease (NAFLD) has been a health problem of growing significance all over the world; its prevalence is increasing in both developed and developing countries ,the overall prevalence of NAFLD worldwide was estimated to be 32.4%.prevalence increased significantly over time. considering the increasing incidence of NALAD/NASH, especially in developed and developing countries, it is anticipated that cirrhosis due to these conditions may exceed other causes of cirrhosis in a near future.. Thyroid gland is involved in energy homeostasis, lipid and carbohydrate metabolism, regulation of body weight and adipogenesis. In a clinical setting, subclinical hypothyroidism has been associated with metabolic syndrome, cardiovascular mortality and disturbance of lipid metabolism. The prevalence of hypothyroidism was reported to 16.8% among patients with NAFLD/NASH. In recent years, growing body of evidence has led to speculation on the association between NAFLD/NASH and thyroid dysfunction. Therefore, understanding the pathophysiology, risk factors and new treatment options of NAFLD/NASH should be among the priorities in the field of hepatology ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06071923
Study type	Observational
Source	Assiut University
Contact	Tasneem Mohammed Ali, Master
Phone	01098704665
Email	Tonamohammed96@gmail.com
Status	Not yet recruiting
Phase
Start date	January 1, 2024
Completion date	February 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05881005` - NAC- NAFLD And Cushing	N/A
Recruiting	`NCT05220956` - Impact of Time-restricted Feeding in NAFLD	N/A
Enrolling by invitation	`NCT04066608` - Prevalence of Advanced Fibrosis in Patients Living With HIV
Recruiting	`NCT04302051` - Assessment of Fatty Liver With Thermo-acoustic Device
Recruiting	`NCT04496895` - The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults	N/A
Recruiting	`NCT05880316` - Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting	N/A
Active, not recruiting	`NCT05898841` - Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load	Phase 4
Completed	`NCT05764811` - SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity	N/A
Active, not recruiting	`NCT05076058` - Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver	N/A
Recruiting	`NCT05421572` - Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Recruiting	`NCT06302049` - Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis	Phase 1/Phase 2
Completed	`NCT04283942` - Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism	N/A
Completed	`NCT01016418` - Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease	Phase 1/Phase 2
Terminated	`NCT04175392` - Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis	Phase 1/Phase 2
Not yet recruiting	`NCT04191044` - Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
Recruiting	`NCT04525833` - Liver Disease and Other Systemic Diseases
Not yet recruiting	`NCT05966025` - Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)	Phase 2
Completed	`NCT04844450` - A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795	Phase 1
Completed	`NCT04367012` - Fatty Liver Among Employees at Banha University
Completed	`NCT05694923` - Effect of Sodium Glucose Cotransporter Inhibitors on Non Diabetic Fatty Liver Disease Patients	N/A